|
Endonovo Therapeutics Inc (ENDV) |
|
Endonovo Therapeutics Inc
ENDV's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Endonovo Therapeutics Inc 's sales fell
by -86.13 % in III. Quarter 2023 from the same quarter a year ago.
Ranking at No. 609
Medical Equipment & Supplies industry recorded
growth of revenues by 5.39 %
Endonovo Therapeutics Inc net loss increased from $-1 millions, to $-1 millions in III. Quarter 2023,
• More on ENDV's Growth
|
|
Endonovo Therapeutics Inc realized a net loss in trailing twelve months.
Endonovo Therapeutics Inc realized cash reduction of $ -0 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 1.06.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.13.
• More on ENDV's Valuation
|
|
|
|
|
Endonovo Therapeutics Inc realized net loss in trailing twelve months.
Endonovo Therapeutics Inc realized cash outflow of $ -0per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 1.06.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.13.
• More on ENDV's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com